Landscapes / Targets
amyloid beta
9 drugs act on amyloid beta, in 23 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs9
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Amyloid-beta protofibril antibody |
Eisai +1 · Public BIIB |
Approved | 3 Dec 2026soonPhase 2 trial completes | ||
| Next date | 3 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Early Alzheimer's Disease, Preclinical Alzheimer's Disease and 2 more | ||||
| Open drug page | |||||
Amyloid-beta antibody (pyroglutamate amyloid beta in plaques) |
Eli Lilly · Public LLY |
Approved | Nov 2027Phase 3 trial completes | ||
| Next date | Nov 2027 · Phase 3 trial completes | ||||
| Also tested for | Alzheimer Disease, Dementia and 13 more | ||||
| Open drug page | |||||
Amyloid-beta antibody with a transferrin receptor brain shuttle |
Roche · Public ROG.SW |
Phase 3 | 31 Jul 2027Phase 1/2 trial completes | ||
| Next date | 31 Jul 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Alzheimers Disease, Alzheimer's Disease | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Dec 2027Phase 3 trial completes | |||
| Next date | 31 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD) | ||||
| Open drug page | |||||
— |
Phase 2/3 | 31 Dec 2027Phase 2/3 trial completes | |||
| Next date | 31 Dec 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Alzheimer Disease, Schizophrenia and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 3 Mar 2028Phase 1/2 trial completes | |||
| Next date | 3 Mar 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Alzheimer Disease | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Apr 2027Phase 1 trial completes | |||
| Next date | 1 Apr 2027 · Phase 1 trial completes | ||||
| Also tested for | Alzheimer Disease, Alzheimer Disease (AD) and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | Sep 2027Phase 1 trial completes | |||
| Next date | Sep 2027 · Phase 1 trial completes | ||||
| Also tested for | Alzheimer's Disease (AD) | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 9 of 9 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026